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Executive Summary 
 
Feeding a growing world population and adapting agricultural production to a changing climate 
is a significant challenge that can be mitigated through the use of new gene-editing technologies 
in crops. However, current regulatory processes are overly burdensome and confusing, have 
limited scientific innovation, and prevent the widespread production of genetically engineered 
(GE) crops. To address this, we propose the regulatory exemption of GE plants that have a 
previously-reviewed trait and mechanism of action, a unified and detailed web platform for 
applications for commercial approval, and the consolidation of federal regulatory communication 
to the USDA. 
 
I. Gene Editing: An Emerging Technology That Could Feed the World  
 
Agricultural production is increasingly strained by changing climate and population growth. 
With the global population expected to reach 9.8 billion by 2050, farmers will have to grow 
about 70% more food than current production.1 Meeting this challenge will require scientific 
advances that bridge the gap between conventional techniques and new technologies in plant 
breeding. 
 
Selective breeding has been used for thousands of years in the domestication of crops to 
artificially select desired traits in foods. More recent breeding techniques have used chemicals to 
induce random DNA mutations, hoping that one of these mutations is involved in a trait of 
interest and spending decades attempting to remove unwanted random mutations through 
breeding. Because these techniques do not introduce foreign DNA into a plant, they are not 
considered to be genetically engineered. 
 
 
1 "Fast Facts About Agriculture & Food." American Farm Bureau Federation. https://www.fb.org/newsroom/fast-
facts. Accessed 13 Apr. 2020. 
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In the past decade, efforts to select for desirable plant traits have drastically increased with new 
biotechnology to more quickly and precisely introduce changes at the genetic level.2 New gene-
editing techniques like CRISPR-Cas9 have revolutionized the field, allowing plant breeders to 
target traits of value with greater speed and precision. This revolution has also allowed smaller, 
non-traditional groups to enter the market. While the creation of GE crops was previously done 
by research universities and industrial agriculture companies, it is increasingly undertaken by 
small to mid-sized innovators. 
 
As a net exporter of agricultural products, particularly to developing countries, the US could see 
significant economic benefits from growth in the agricultural sector.3 Despite the fact that the US 
plants the largest acreage of GE crops in the world (40% of the global total), the development of 
GE crops in the US has not been able to reach its full potential.4 This is primarily due to costs 
associated with the complicated regulatory process. 
 
It is expensive to bring a GE crop from the laboratory bench to commercial distribution, 
averaging $130 million and 7 years (13 years including R&D) for a single crop in the US.5 For 
this reason, GE research has focused on staple crops like corn and wheat. However, major 
agricultural producers, such as California, produce few of these staple crops, despite exporting 
15% of US agriculture.6 The multibillion-dollar California agriculture market, including all US 
production of specialty crops including grapes, almonds, and pistachios, is ripe with high-value 
products that will undoubtedly be the future of gene editing.3 The proliferation of these new 
techniques and the rapid growth in developers has raised issues around the regulation of 
genetically modified crops. 
 
II. Existing Policy Framework: Federal and State  
 
GE plant regulatory policy is primarily created and implemented by three federal agencies: the 
Environmental Protection Agency (EPA), the Food and Drug Administration (FDA), and the 
United States Department of Agriculture (USDA). These agencies regulate different types and 
features of GE crops, depending on the specific use of the crop and how it was produced. Their 
 
2 Kuzma, J. "Regulating Gene-Edited Crops." Issues in Science and Technology. 2018. https://issues.org/regulating-
gene-edited-crops/. Accessed 12 Apr. 2020. 
3 Kraybill, D., Mercier, S., Glauber, J. "How the United States Benefits from Agricultural and Food Security 
Investments in Developing Countries." The Association of Public & Land-grant Universities. 
https://www.aplu.org/library/how-the-united-states-benefits-from-agricultural-and-food-security-investments-in-
developing-countries/file. Accessed 13 Apr. 2020. 
4 James, C. "Global Status of Commercialized Biotech/GM Crops: 2014." The International Service for the 
Acquisition of Agri-biotech Applications. 2014. 
https://isaaa.org/resources/publications/briefs/49/toptenfacts/default.asp. Accessed 12 Apr. 2020. 
5 "What does it take to bring a new GM product to market?" https://gmo.geneticliteracyproject.org/FAQ/what-does-
it-take-to-bring-a-new-gm-product-to-market/. Accessed 13 Apr. 2020. 
6 "California Agricultural Exports 2017-2018." California Department of Food and Agriculture. 
https://www.cdfa.ca.gov/statistics/PDFs/2017-18AgExports.pdf. Accessed 12 Apr. 2020. 
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responsibilities regarding GE crops are outlined by the 2017 Update to the Coordinated 
Framework for the Regulation of Biotechnology7 and the 2019 Executive Order 13874 
(EO13874).8 
 
Here, we focus on the role of the USDA in biotechnology regulation as it is the agency with the 
most recent updated regulations in response to EO13874. Within the USDA, the Animal and 
Plant Health Inspection Service (APHIS) is the main agency responsible for regulating GE crops 
and other products of biotechnology. APHIS focuses on products that may pose a risk to 
agricultural plant and animal health. For example, in November 2018, APHIS decided that a 
Pichia kudriavzevii mutant manufactured by Lygos, Inc. should be regulated.9,10 This was in 
accordance with APHIS’ mission to regulate potential plant pests; P. kudriavzevii is a fungus 
known to cause disease in citrus and grapes. 
 
APHIS proposed an updated regulatory policy in June 2019: the Movement of Certain 
Genetically Engineered Organisms.11 This rule is still in review (as of March 12, 2020),12 but it 
aims to reduce “regulatory burden for developers of organisms that are unlikely to pose plant 
pest risks”. One key element of the proposed regulation is the allowance for developers to self-
determine exemption for their GE plant by comparing it to all plants with completed regulatory 
reviews, with the option to request written confirmation from APHIS. In an attempt to support 
accurate self-determinations, APHIS proposes the creation of a publicly-accessible database 
containing the results of all completed regulatory status reviews, including each reviewed 
combination of plant, trait, and mechanism of action (MOA, or the way a trait is expressed).  
 
State-level legislation has little effect on this process because in most states, there are few state-
level regulations surrounding GE agriculture. California follows this pattern; in most areas 
regarding biotechnology, the state defers to federal regulations. The handful of statewide 
 
7 "2017 Update to the Coordinated Framework for the Regulation." 
https://obamawhitehouse.archives.gov/sites/default/files/microsites/ostp/2017_coordinated_framework_update.pdf. 
Accessed 12 Apr. 2020. 
8 "Executive Order on Modernizing the Regulatory Framework for Agricultural Biotechnology Products." 11 Jun. 
2019, https://www.whitehouse.gov/presidential-actions/executive-order-modernizing-regulatory-framework-
agricultural-biotechnology-products/. Accessed 12 Apr. 2020. 
9 “Am I Regulated CBI-Deleted Copy, 18-208-01.” USDA APHIS. 17 Oct. 2018, 
https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/18-208-01_a3_air_cbidel.pdf. Accessed 12 Apr. 
2020.  
10 “Am I Regulated Response, 18-208-01.” USDA APHIS. 29 Nov. 2018, 
https://www.aphis.usda.gov/biotechnology/downloads/reg_loi/18-208-01_air_response_signed.pdf. Accessed 12 
Apr. 2020.  
11 "Movement of Certain Genetically Engineered Organisms." 6 Jun. 2019, 
https://www.federalregister.gov/documents/2019/06/06/2019-11704/movement-of-certain-genetically-engineered-
organisms. Accessed 13 Apr. 2020. 
12 "Updating Biotechnology Regulations.” USDA APHIS. 12 Mar. 2020, 
https://www.aphis.usda.gov/aphis/ourfocus/biotechnology/biotech-rule-revision. Accessed 12 Apr. 2020. 
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regulations that do exist are haphazard and incoherent, such as bans on individual organisms.13 
The most important California legislation relevant to GE organisms is SB 839 (2016),14 which 
permits cities, counties, and districts to ban certain types of crops within their jurisdictions. To 
date, five contiguous Northern California counties forming a 9-million acre region - plus Santa 
Cruz - ban the cultivation of GE crops. 
 
While recent federal actions have sought to clarify and modernize regulation, significant barriers 
to scaling up the production of GE products still exist. Together, the 2017 Coordinated 
Framework Update and EO13874 outline the need for a unified and straightforward process for 
the approval of new biotechnologies, but the specifics of such a process are weakly defined at 
present. While EO13874 calls for the creation of a Unified Biotechnology Web-based Platform, 
the current iteration is a website with internal redundancies and links to a confusing web of 
regulations, leaving the user frustrated and with limited additional information. Updated 
regulation is in flux, with the relevant agencies still developing their updated approach.  
 
III. Policy Recommendations 
 
We recommend several measures to address the above shortcomings and provide a clear path to 
safely and efficiently bring GE crops to market. 
 
First, while we support APHIS creation of a database of all completed regulatory reviews to help 
developers make self determinations, we argue that the proposed use does not go far enough. 
APHIS states that developers whose GE plant has the same plant-trait-MOA combination as a 
previously-reviewed organism could easily self determine non-regulation by APHIS.15 
Developers must request a review or permit if their GE plant has not been previously reviewed 
and does not fit into another exempted category. We argue that this exemption for previously-
reviewed plant-trait-MOA combinations applies to few GE plants and provides no significant 
relief of regulatory burden. Instead, we propose that APHIS extend this exemption to GE plants 
with a previously-reviewed trait-MOA combination that is combined with a new plant. If a trait-
MOA combination is reviewed in one plant and determined to cause no plant pest risk, then it is 
unlikely to cause a plant pest risk in a different plant. This is consistent with APHIS’ attempt to 
create more risk-based regulation and reduce regulatory burden. 
 
 
13 Weiss, K. "From Biogenics Lab to Home Aquariums, It's the GloFish." Los Angeles Times. 22 Nov. 2003. 
https://www.latimes.com/archives/la-xpm-2003-nov-22-me-glofish22-story.html. Accessed 12 Apr. 2020. 
14 "SB-839 Public resources.” 13 Sep. 2016, 
https://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=201520160SB839. Accessed 12 Apr. 2020. 
15 "Movement of Certain Genetically Engineered Organisms." 6 Jun. 2019, 
https://www.federalregister.gov/documents/2019/06/06/2019-11704/movement-of-certain-genetically-engineered-
organisms. Accessed 14 Apr. 2020. 
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Second, the agencies should push an agenda that supports implementation of clarifying web-
based platforms. EO13874’s recommended Unified Biotechnology Web-Based Platform 
provides the foundation for improvement, but does not go far enough. The platform should 
contain more than just descriptions for the regulatory roles of the USDA, FDA, and EPA as it 
does now.16 While the site also allows users to contact the agencies with questions regarding 
regulation, a far better use of the platform would be an avenue to submit an application for 
commercial approval of a biotechnology product. The web platform currently states that “[each] 
regulatory agency has its own specific application procedures” but does little more than offer 
links to each website.15 If the goal of the current regulatory modernization is to streamline and 
clarify the process of GE plant approval, then the unified web platform should serve as a tool to 
help small and midsize producers begin the process of product approval. 
 
Third, as the agencies update their regulations they must focus on clarity and consolidation of 
communication regarding the GE plant approval process. The current proposal, albeit improved, 
fails to simplify the regulatory process in a way that makes it accessible to small to medium 
sized innovators who have no previous experience with regulation. Agencies should coordinate 
their response to inquiries in addition to improvement of the aforementioned unified web 
platform. Since the USDA is currently the designated funder of the consolidated web-based 
platform (by EO13874), we propose assigning coordination to the USDA. This agency is best 
poised to oversee regulations by using its EO13874-mandated appropriations to develop and 
manage a clearinghouse for all GE-related inquiries. The USDA would thereby serve as a liaison 
between all three federal regulators and innovators, benefitting innovators and the agencies alike. 
 
IV. Potential Limitations 
 
By simplifying the GE regulatory requirements, the process of taking a GE crop to market will 
be more transparent and navigable for small to medium sized companies. However, a policy that 
extends exemptions will also benefit established companies with proprietary traits that have 
already undergone federal inspection and are better poised to scale up those traits into new crops. 
This may make it harder for small innovators to succeed in the market. 
 
If new proposals are implemented, the USDA will absorb new roles for the overall efficiency of 
the regulatory process. However, the agency will also have a greatly decreased regulatory burden 
since many new gene-edited crops will be exempt from USDA regulation. Still, the USDA may 
not have sufficient capacity to handle requests without a corresponding increase in funding to 
hire personnel to manage these new roles. 
 
V. Conclusion 
 
16 “The Unified Website for Biotechnology Regulation.” USDA, FDA, and EPA. 
https://usbiotechnologyregulation.mrp.usda.gov/biotechnologygov/home. Accessed 10 Apr. 2020.  
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We recommend the regulatory exemption of GE plants with a previously-reviewed trait-MOA 
combination, a unified and detailed web platform for applications for commercial approval, and 
the consolidation of federal regulatory communication to the USDA. If implemented, our 
proposals will reduce regulatory burdens on companies and researchers seeking to bring new 
products to market without eliminating meaningful safety and consumer protection standards. An 
extension of the regulatory exemption to more GE plant products will likely bring the greatest 
benefit to large firms, since it will be easier for them to adjust their techniques to bring the same 
trait to different plants. It will also allow the USDA more time to focus on regulation of novel 
GE crops, which have completely new traits or mechanisms of action. Meanwhile, the proposals 
to consolidate oversight and implement regulations in a clear way will accommodate smaller 
firms and researchers, who do not have legal staff or experience with handling federal 
regulations. These stakeholders will face lower financial and time constraints. 
 
With a clearer and more streamlined process, the US will see a proliferation of GE crops. Small 
to mid-sized innovators may find niche markets in editing crops that lag in breeding efficiency. 
These benefits will be particularly fruitful in California, as specialty crops like grapes, almonds, 
and pistachios are ripe for rapid advancements. The California agricultural sector also awaits 
innovations that will increase adaptation to the worsening threats of climate change such as fire, 
drought, and flooding. If federal policy keeps up with these advancements by streamlining and 
demystifying regulations, the United States will benefit from crops that are safer, cheaper, and 
more resilient. 
